Hrt Financial LP Fennec Pharmaceuticals Inc. Transaction History

Hrt Financial LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$7.38 - $10.35 $403,206 - $565,472	54,635 New	54,635 $454,000
Q4 2021 Feb 14, 2022	SELL	$3.89 - $10.01 $217,587 - $559,909	-55,935 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$6.51 - $9.62 $39,418 - $58,249	-6,055 Reduced 9.77%	55,935 $526,000
Q2 2021 Aug 16, 2021	BUY	$5.96 - $7.85 $369,460 - $486,621	61,990 New	61,990 $451,000

14.9M

10K

83.8K

Ticker FENC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,067,300
Market Cap $156M
Description
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.